Seagen Inc.
(NASDAQ : SGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 0.14%573.222.7%$665.82m
AMGNAmgen, Inc. -0.72%227.331.3%$582.97m
ILMNIllumina, Inc. 2.10%324.533.5%$567.14m
GILDGilead Sciences, Inc. 0.07%60.251.0%$501.68m
MRNAModerna, Inc. 3.79%70.960.0%$489.60m
VRTXVertex Pharmaceuticals, Inc. -0.26%210.831.9%$487.08m
ARRYArray BioPharma Inc. 0.74%39.6314.2%$481.88m
IMMUImmunomedics, Inc. 0.05%87.8711.0%$373.48m
NVAXNovavax, Inc. 2.55%93.4896.5%$310.50m
ALXNAlexion Pharmaceuticals, Inc. 1.91%120.452.0%$285.78m
BIIBBiogen, Inc. -1.85%263.921.6%$259.69m
EXASEXACT Sciences Corp. 7.21%106.8020.7%$235.39m
BNTXBioNTech SE -1.78%86.160.0%$210.85m
SRNESorrento Therapeutics, Inc. 5.29%8.271.4%$191.03m
SGENSeagen Inc. 1.61%200.906.0%$164.98m

Company Profile

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.